Ampio Pharmaceuticals, Inc. (NYSEAMERICAN:AMPE) Short Interest Update

Ampio Pharmaceuticals, Inc. (NYSEAMERICAN:AMPE – Get Rating) was the target of a significant drop in short interest in May. As of May 31st, there was short interest totalling 446,900 shares, a drop of 40.3% from the May 15th total of 748,600 shares. Currently, 3.2% of the company’s stock are sold short. Based on an average […]

Related Keywords

,Vanguard Group Inc ,Ampio Pharmaceuticals Price Performance ,Ampio Pharmaceuticals ,Ampio Pharmaceuticals Inc ,Millennium Management ,Pricet Rowe Associates Inc ,Ampio Pharmaceuticals Company Profile ,Hedge Funds Weigh In On Ampio Pharmaceuticals ,News Ratings For Ampio Pharmaceuticals Daily ,Get Rating ,Sigma Advisers ,Ampio Pharmaceuticals Daily ,Nyseamerican Ampe ,Ampe ,Medical ,03209t10 ,Stocks ,Options ,Put ,Call ,